NUDT19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.125400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.145800E-01
Normal-vs-Stage2
5.179000E-01
Normal-vs-Stage3
6.093000E-01
Normal-vs-Stage4
9.718000E-01
Stage1-vs-Stage2
9.455000E-01
Stage1-vs-Stage3
1.964630E-01
Stage1-vs-Stage4
4.918600E-01
Stage2-vs-Stage3
2.335400E-01
Stage2-vs-Stage4
4.858000E-01
Stage3-vs-Stage4
6.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.043800E-01
Normal-vs-AfricanAmerican
6.736200E-01
Normal-vs-Asian
4.534800E-01
Caucasian-vs-AfricanAmerican
9.348400E-01
Caucasian-vs-Asian
6.793800E-01
AfricanAmerican-vs-Asian
9.179200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.843800E-01
Normal-vs-Female
5.392400E-01
Male-vs-Female
8.861400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.326160E-01
Normal-vs-Age(41-60Yrs)
3.769800E-01
Normal-vs-Age(61-80Yrs)
6.108600E-01
Normal-vs-Age(81-100Yrs)
6.256400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.069600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.595000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.411600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.544500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.418600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.573600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.952600E-01
Normal-vs-Daily Drinker
4.282600E-01
Normal-vs-Weekly Drinker
5.527400E-01
Normal-vs-Occasional Drinker
1.396220E-01
Normal-vs-Social Drinker
5.733600E-01
Non Drinker-vs-Daily Drinker
1.606590E-01
Non Drinker-vs-Weekly Drinker
3.518200E-01
Non Drinker-vs-Occasional Drinker
5.544800E-03
Non Drinker-vs-Social Drinker
5.149600E-01
Daily Drinker-vs-Weekly Drinker
9.451200E-01
Daily Drinker-vs-Occasional Drinker
2.217600E-01
Daily Drinker-vs-Social Drinker
5.534000E-01
Weekly Drinker-vs-Occasional Drinker
3.951400E-01
Weekly Drinker-vs-Social Drinker
6.151800E-01
Occasional Drinker-vs-Social Drinker
7.697800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.346600E-01
Normal-vs-Grade 2
7.542800E-01
Normal-vs-Grade 3
7.458200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.504600E-01
Grade 1-vs-Grade 3
7.542600E-01
Grade 1-vs-Grade 4
7.346600E-01
Grade 2-vs-Grade 3
7.186200E-01
Grade 2-vs-Grade 4
7.542800E-01
Grade 3-vs-Grade 4
7.458200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.729200E-01
Normal-vs-NonDiabetic
4.516200E-01
Diabetic-vs-NonDiabetic
5.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.810600E-01
Normal-vs-NoPancreatitis
4.912400E-01
Pancreatitis-vs-NoPancreatitis
2.945800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.238000E-01
Normal-vs-N1
5.309600E-01
N0-vs-N1
8.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.597000E-01
Normal-vs-TP53-NonMutant
9.222000E-01
TP53-Mutant-vs-TP53-NonMutant
1.206740E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
